Oscar Health (OSCR) Return on Sales (2020 - 2025)
Oscar Health (OSCR) has disclosed Return on Sales for 6 consecutive years, with 0.13% as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Return on Sales fell 6.0% year-over-year to 0.13%, compared with a TTM value of 0.04% through Dec 2025, down 4.0%, and an annual FY2025 reading of 0.04%, down 4.0% over the prior year.
- Return on Sales was 0.13% for Q4 2025 at Oscar Health, down from 0.04% in the prior quarter.
- Across five years, Return on Sales topped out at 0.09% in Q1 2025 and bottomed at 296.27% in Q1 2021.
- Average Return on Sales over 5 years is 32.42%, with a median of 0.07% recorded in 2024.
- The sharpest move saw Return on Sales plummeted -29513bps in 2021, then surged 29209bps in 2022.
- Year by year, Return on Sales stood at 0.11% in 2021, then soared by 172bps to 0.08% in 2022, then tumbled by -55bps to 0.04% in 2023, then plummeted by -287bps to 0.07% in 2024, then crashed by -92bps to 0.13% in 2025.
- Business Quant data shows Return on Sales for OSCR at 0.13% in Q4 2025, 0.04% in Q3 2025, and 0.08% in Q2 2025.